Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network
Authors:
- 25 January 2012
- journal article
- review article
- Published by Springer Nature in Genes & Nutrition
- Vol. 7 (2) , 111-125
Abstract
Signal transducers and activators of transcription (STAT) proteins were described as a family of latent cytosolic transcription factors whose activation is dependent on phosphorylation via growth factor- and cytokine-membrane receptors including interferon and interleukin, or by non-receptor intracellular tyrosine kinases, including Src. A vast majority of natural substances are capable of modulating mitogenic signals, cell survival, apoptosis, cell cycle regulation, angiogenesis as well as processes involved in metastasis development. The inhibition of STAT3 phosphorylation by natural and dietary compounds leads to decreased protein expression of STAT3 targets essentially involved in regulation of the cell cycle and apoptotic cell death. This review details the cell signaling pathways involving STAT transcription factors as well as the corresponding compounds from nature able to interfere with this regulatory system in human cancer.Keywords
This publication has 107 references indexed in Scilit:
- Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathwaysCarcinogenesis, 2011
- γ‐Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro‐apoptotic and chemosensitizing agentBritish Journal of Pharmacology, 2010
- Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathwayBritish Journal of Pharmacology, 2010
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancerCytokine & Growth Factor Reviews, 2010
- Inteferons pen the JAK–STAT pathwaySeminars in Cell & Developmental Biology, 2008
- Prostate cancerThe Lancet, 2008
- Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activityProceedings of the National Academy of Sciences, 2007
- Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domainGenes & Development, 2006
- Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivityBritish Journal of Cancer, 1999
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996